Related Experiment Videos
Human beta-globin gene expression after gene transfer using retroviral vectors.
1Department of Pediatrics, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
DNA (Mary Ann Liebert, Inc.)
|December 1, 1987
Summary
Retroviral vectors successfully transferred and expressed the human beta-S-globin gene in mouse erythroid cells. These cells showed appropriate gene regulation, unlike non-erythroid cells.
Area of Science:
- Molecular Biology
- Gene Therapy
- Hematology
Background:
- Gene therapy holds promise for treating genetic blood disorders.
- Understanding gene expression regulation in erythroid cells is crucial.
Purpose of the Study:
- To evaluate the efficacy of retroviral vectors for transferring and expressing the human beta-S-globin gene in erythroid cells.
- To assess the appropriate regulation of human beta-globin gene expression in different cell types.
Main Methods:
- Utilized a retroviral vector carrying the human beta-S-globin gene and a neomycin resistance gene.
- Infected NIH-3T3 (non-erythroid) and mouse erythroleukemia cells (MELC, erythroid).
- Analyzed human beta-globin mRNA transcription, initiation, splicing, and regulation upon DMSO induction.
Main Results:
- MELC demonstrated proper transcription, initiation, and splicing of human beta-globin mRNA.
- DMSO induction led to increased beta-globin mRNA in some MELC, indicating regulated expression.
- NIH-3T3 cells showed limited globin mRNA accumulation and lacked appropriate regulation.
- Induced MELC clones exhibited 2-3% of endogenous mouse beta-globin gene expression levels.
Conclusions:
- Retroviral vectors are effective tools for transferring human beta-globin genes into erythroid cells.
- Erythroid cells provide a suitable environment for appropriate regulation of transferred human beta-globin genes.
- This study supports the potential of retroviral gene transfer for treating beta-globin-related disorders.